EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Overexposure to venetoclax is associated with prolonged-duration of neutropenia during venetoclax and azacitidine therapy in Japanese patients with acute myeloid leukemia

Takahiro Kobayashi iD, Honami Sato, Masatomo Miura, Yayoi Fukushi, Wataru Kuroki, Fumiko Ito, Kazuaki Teshima, Atsushi Watanabe, Naohito Fujishima, Isuzu Kobayashi, Yoshihiro Kameoka, Naoto Takahashi

Cancer Chemotherapy and Pharmacology · 2024

DOI: 10.1007/s00280-024-04673-5 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Cancer Chemotherapy and Pharmacology, 2024. Verfasst von Takahiro Kobayashi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Nephrology and Rheumatology, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita City, Akita, Japan. takahiro@…. Hauptthemen laut MEDLINE: Azacitidine, Bridged Bicyclo Compounds, Heterocyclic, Leukemia, Myeloid, Acute, Neutropenia. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: Otsuka Pharmaceutical, Novartis Japan, Astellas Pharma.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AzacitidineBridged Bicyclo Compounds, HeterocyclicLeukemia, Myeloid, AcuteNeutropeniaSulfonamidesAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedAntineoplastic Combined Chemotherapy ProtocolsArea Under CurveEast Asian PeopleJapan

Stichwörter der Autor:innen

AUC0–24Acute myeloid leukemiaAzacitidineNeutropeniaPlasma concentrationVenetoclax

Substanzen

AzacitidineBridged Bicyclo Compounds, HeterocyclicSulfonamidesvenetoclax

Autor:innen und Institutionen

  • Department of Hematology, Nephrology and Rheumatology, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita City, Akita, Japan. takahiro@med.akita-u.ac.jp.
  • Department of Hematology, Nephrology and Rheumatology, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita City, Akita, Japan.
  • Department of Pharmacokinetics, Akita University Graduate School of Medicine, Akita, Japan.
  • Department of Pharmacy, Akita University Hospital, Akita, Japan.
  • Department of Internal Medicine, Yuri Kumiai General Hospital, Yurihonjo, Japan.
  • Department of Hematology, Akita City Hospital, Akita, Japan.

ORCID-Profile: Takahiro Kobayashi

Förderung

  • Otsuka Pharmaceutical
  • Novartis Japan
  • Astellas Pharma
  • Asahikasei Pharma Japan
  • Ono Pharmaceutical

Zitieren

APA

Kobayashi, T., Sato, H., Miura, M., Fukushi, Y., Kuroki, W., Ito, F., Teshima, K., Watanabe, A., Fujishima, N., Kobayashi, I., Kameoka, Y., & Takahashi, N. (2024). Overexposure to venetoclax is associated with prolonged-duration of neutropenia during venetoclax and azacitidine therapy in Japanese patients with acute myeloid leukemia. Cancer Chemotherapy and Pharmacology. https://doi.org/10.1007/s00280-024-04673-5

Vancouver

Kobayashi T, Sato H, Miura M, Fukushi Y, Kuroki W, Ito F, et al. Overexposure to venetoclax is associated with prolonged-duration of neutropenia during venetoclax and azacitidine therapy in Japanese patients with acute myeloid leukemia. Cancer Chemotherapy and Pharmacology. 2024. doi:10.1007/s00280-024-04673-5

BibTeX
@article{Kobayashi2024,
  author = {Kobayashi, Takahiro and Sato, Honami and Miura, Masatomo and Fukushi, Yayoi and Kuroki, Wataru and Ito, Fumiko and Teshima, Kazuaki and Watanabe, Atsushi and Fujishima, Naohito and Kobayashi, Isuzu and Kameoka, Yoshihiro and Takahashi, Naoto},
  title = {Overexposure to venetoclax is associated with prolonged-duration of neutropenia during venetoclax and azacitidine therapy in Japanese patients with acute myeloid leukemia},
  journal = {Cancer Chemotherapy and Pharmacology},
  year = {2024},
  doi = {10.1007/s00280-024-04673-5}
}
Kostenlos starten →